Therefore, future studies assessing ATF6 and/or PERK pathways would be useful to gain a mechanistic understanding of UPR activation in the liver in the context of obesity and aging and in the response to dietary DHA supplementation and/or exercise. Here, ATF6 is linked to obesity due to melanocortin 4 receptor deficiency.